Kennedy Investment Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$914K Sell
3,847
-13
-0.3% -$2.7K 0.31% 73
2026
Q1
$816K Sell
3,860
-266
-6% -$57.3K 0.32% 73
2025
Q4
$848K Sell
4,126
-50
-1% -$9.41K 0.32% 71
2025
Q3
$655K Sell
4,176
-211
-5% -$32.6K 0.26% 81
2025
Q2
$737K Sell
4,387
-74
-2% -$11K 0.31% 72
2025
Q1
$615K Buy
4,461
+11
+0.2% +$1.4K 0.29% 80
2024
Q4
$526K Buy
4,450
+46
+1% +$5.37K 0.24% 83
2024
Q3
$487K Sell
4,404
-67
-1% -$7K 0.22% 86
2024
Q2
$440K Buy
4,471
+148
+3% +$15.1K 0.22% 87
2024
Q1
$484K Sell
4,323
-22
-0.5% -$2.37K 0.26% 81
2023
Q4
$438K Sell
4,345
-99
-2% -$9.82K 0.24% 86
2023
Q3
$386K Sell
4,444
-11
-0.2% -$994 0.23% 89
2023
Q2
$421K Buy
4,455
+27
+0.6% +$2.28K 0.25% 84
2023
Q1
$334K Sell
4,428
-16
-0.4% -$1.21K 0.2% 91
2022
Q4
$342K Buy
+4,444
New +$338K 0.22% 91

Other funds holding CAH

Kennedy Investment Group's CAH Position: Q2 2026 in Review

Kennedy Investment Group reduced its Cardinal Health (CAH) stake by 0.34% in Q2 2026, selling an estimated $2.7K and leaving 3,847 shares worth $914K. The position accounts for 0.31% of the portfolio, ranked #73.

Kennedy Investment Group first reported a position in CAH in Q4 2022 and has held it in 15 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Kennedy Investment Group held 3,847 shares of Cardinal Health worth $914K as of Q2 2026.
  • Kennedy Investment Group sold 13 Cardinal Health shares in Q2 2026, an estimated $2.7K.
  • Cardinal Health made up 0.31% of Kennedy Investment Group's portfolio in Q2 2026, its #73 holding.
  • Kennedy Investment Group first reported a position in Cardinal Health in Q4 2022 and has held it in 15 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Kennedy Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.